We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA announced in a new guidance that it does not plan to object to delays in adverse event reporting for medical products during the pandemic. Read More
The FDA issued a new policy that allows the use of validated COVID-19 diagnostics while the agency reviews Emergency Use Authorization (EUA) requests. Read More
Drugmakers are reporting shortages of two drugs needed for ventilator patients as demand increases due to COVID-19, propofol and dexmedetomidine. Read More
The EMA said it will allow firms struggling to meet quality requirements when they increase manufacturing capacity to meet demand during the COVID-19 pandemic to use a risk-based approach. Read More
The World Health Organization (WHO) has reported that there are 70 novel coronavirus vaccines in development around the globe with three already in human trials. Read More